Preclinical Imaging Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

The rapidly rising number of rare diseases and orphan diseases increases the demand for the development of novel drugs resulting in the soaring market for pre-clinical research. Furthermore, the involvement of contract research organizations in the pharmaceutical market has a significant effect on the growth of the pre-clinical imaging market. Additionally, the increasing number of drug approvals also compelling the market growth of the pre-clinical trials. For instance, As per CBO, Between 2010 and 2019, the number of new drugs approved for sale increased by 60 percent compared with the previous decade.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22817

According to UnivDatos Market Insights (UMI)’ research report “Global Preclinical Imaging Market Analysis, 2021”, the preclinical imaging market is projected to grow at a CAGR of ~5% during 2021-27F. Deteriorating health coupled with the rising cost of medical treatment is one of the major reasons of concern across the globe owing to the advancement in medical technology. These factors are driving the worldwide demand for efficient diagnostic imaging solutions augmenting the growth of the preclinical imaging market globally.

Based on the product, the market is segmented into CT imaging, MRI imaging, PET/SPECT imaging, multi-modal imaging, optical imaging, ultrasound imaging, photoacoustic imaging, reagents, and services. The multi-modal imaging segment is anticipated to witness significant market growth during the forecast period. The multi-modal imaging systems use different techniques for visualization. Furthermore, increasing cases of multiple organ failure and increasing demand for medicines that can treat different drugs are attributed to the significant market share of the segment during the foreseeable future. For instance, as per CDC, High blood sugar can slowly damage the kidneys, and, over time, they can stop filtering blood as well as they should, leading to chronic kidney disease and approximately 1 in 3 adults with diabetes has chronic kidney disease.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22817

Based on the application, the market is segmented into oncology, neurology, cardiology, infectious diseases, and others. The cardiology segment is predicted to have considerable market growth during the forecast period. This is due to the rising prevalence of cardiovascular disorders and the diseases related to them such as diabetes and hypertension. For instance, as per the CDC, 116 million adults in the United States have hypertension.

North America to Grab Lion’s Share, and witnessed Explicit Growth

Based on the region, North America dominated the global preclinical imaging market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the well-established market players and frequent product launches. North America is expected to skyrocket with a robust CAGR during the forecast period owing, as stated in UnivDatos Market Insights (UMI)’ research report “Global Preclinical Imaging Market Analysis, 2021”. 

For more informative information, please visit us – https://univdatos.com/report/preclinical-imaging-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the ultrasonic electrosurgical device market include Bruker Corporation, Siemens AG, General Electric (GE), TriFoil Imaging, PerkinElmer Inc., VisualSonics Inc. (Fujifilm), Mediso Ltd., Agilent Technologies, MILabs B.V., and MR Solutions, among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global Preclinical Imaging Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for preclinical imaging providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/preclinical-imaging-market/

Market Segmentation:

1.      By Product (CT imaging, MRI imaging, PET/SPECT imaging, Multi-Modal Imaging, Optical Imaging, Ultrasound Imaging, Photoacoustic Imaging, Reagents, and Services.)

2.      By Application (Oncology, Neurology, Cardiology, Infectious Diseases, and Others)

3.      By Region (North America, Europe, Asia-Pacific, Rest of the World)

4.      By Company (Bruker Corporation, Siemens AG, General Electric, TriFoil Imaging, PerkinElmer, Inc., VisualSonics Inc. (Fujifilm), Mediso Ltd., Agilent Technologies, MILabs B.V., and MR Solutions., etc.)

Key questions answered in the study:

1.      What are the current and future trends of the preclinical imaging industry?

2.      How the industry has been evolving in terms of product and application?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the preclinical imaging industry?

5.      What is the customer orientation, purchase behavior, and expectations from the preclinical imaging firms across various regions?

 

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL PRECLINICAL IMAGING MARKET COVID-19 IMPACT

6 GLOBAL PRECLINICAL IMAGING MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT

8 MARKET INSIGHTS BY APPLICATION

9 MARKET INSIGHTS BY REGION

10 PRECLINICAL IMAGING MARKET DYNAMICS

11 PRECLINICAL IMAGING MARKET OPPORTUNITIES

12 PRECLINICAL IMAGING MARKET TRENDS

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY-SIDE ANALYSIS

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

17 COMPANY PROFILED

18 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·        3D Bioprinting of Living Human Tissues/Organs Market is growing by leaps and bounds with Top Key players like 3Dynamic Systems, Aspect Biosystems, Allevi, BioDan

·        Lack of Donors Driving the Wearable Artificial Organs Market: Current Analysis and Forecast with Different Segments, Key Players Insights

·        Mobile Health Application (mHealth Apps) Market to Reach US$ 315.4 Billion by 2027, Globally |CAGR: 44.4%

Nanotechnology in Drug Delivery Market to Reach US$ 182.3 Billion by 2027, Globally | CAGR: 19.9% |